NZ207038A - Process for producing highly crystalline sodium cefoperazone - Google Patents
Process for producing highly crystalline sodium cefoperazoneInfo
- Publication number
 - NZ207038A NZ207038A NZ207038A NZ20703884A NZ207038A NZ 207038 A NZ207038 A NZ 207038A NZ 207038 A NZ207038 A NZ 207038A NZ 20703884 A NZ20703884 A NZ 20703884A NZ 207038 A NZ207038 A NZ 207038A
 - Authority
 - NZ
 - New Zealand
 - Prior art keywords
 - acetone
 - cefoperazone
 - sodium
 - water
 - solution
 - Prior art date
 
Links
Classifications
- 
        
- C—CHEMISTRY; METALLURGY
 - C07—ORGANIC CHEMISTRY
 - C07D—HETEROCYCLIC COMPOUNDS
 - C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
 - C07D501/14—Compounds having a nitrogen atom directly attached in position 7
 - C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
 - C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
 - C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
 - C07D501/36—Methylene radicals, substituted by sulfur atoms
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
 - A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
 - A61P31/04—Antibacterial agents
 
 
Landscapes
- Chemical & Material Sciences (AREA)
 - Organic Chemistry (AREA)
 - Health & Medical Sciences (AREA)
 - Chemical Kinetics & Catalysis (AREA)
 - Life Sciences & Earth Sciences (AREA)
 - General Chemical & Material Sciences (AREA)
 - Medicinal Chemistry (AREA)
 - Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
 - Communicable Diseases (AREA)
 - Pharmacology & Pharmacy (AREA)
 - Oncology (AREA)
 - Animal Behavior & Ethology (AREA)
 - General Health & Medical Sciences (AREA)
 - Public Health (AREA)
 - Veterinary Medicine (AREA)
 - Cephalosporin Compounds (AREA)
 - Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
 
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US06/464,223 US4456753A (en) | 1983-02-07 | 1983-02-07 | Process for the manufacture of highly crystalline sodium cefoperazone | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| NZ207038A true NZ207038A (en) | 1986-05-09 | 
Family
ID=23843028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| NZ207038A NZ207038A (en) | 1983-02-07 | 1984-02-03 | Process for producing highly crystalline sodium cefoperazone | 
Country Status (22)
| Country | Link | 
|---|---|
| US (1) | US4456753A (instruction) | 
| EP (1) | EP0118196B1 (instruction) | 
| JP (1) | JPH0643429B2 (instruction) | 
| KR (1) | KR870001071B1 (instruction) | 
| AU (1) | AU541675B2 (instruction) | 
| CA (1) | CA1190220A (instruction) | 
| DE (1) | DE3461802D1 (instruction) | 
| DK (1) | DK152757C (instruction) | 
| ES (1) | ES8504700A1 (instruction) | 
| FI (1) | FI75571C (instruction) | 
| GR (1) | GR81694B (instruction) | 
| HK (1) | HK99687A (instruction) | 
| HU (1) | HU190544B (instruction) | 
| IE (1) | IE56752B1 (instruction) | 
| IL (1) | IL70872A (instruction) | 
| NZ (1) | NZ207038A (instruction) | 
| PH (1) | PH19052A (instruction) | 
| PL (1) | PL146540B1 (instruction) | 
| PT (1) | PT78058B (instruction) | 
| SG (1) | SG70087G (instruction) | 
| YU (1) | YU43562B (instruction) | 
| ZA (1) | ZA84853B (instruction) | 
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| WO1997003959A1 (en) | 1995-07-17 | 1997-02-06 | Warner-Lambert Company | Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) | 
| WO1999024441A1 (en) * | 1997-11-10 | 1999-05-20 | Dsm N.V. | Crystallization of beta-lactam compounds | 
| MXPA01009808A (es) | 1999-04-01 | 2002-04-24 | Dsm Nv | Aglomerados por cristalizacion. | 
| IT1318467B1 (it) * | 2000-04-14 | 2003-08-25 | Antibioticos Spa | Processo per la sintesi di cefoperazone sodico ad elevatacristallinita'. | 
| WO2007035911A1 (en) * | 2005-09-21 | 2007-03-29 | Novabay Pharmaceuticals, Inc. | System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions | 
| CN101863907B (zh) * | 2010-07-07 | 2012-05-23 | 福建省福抗药业股份有限公司 | 一种头孢哌酮钠的结晶方法 | 
| WO2014012849A1 (en) * | 2012-07-17 | 2014-01-23 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | A new crystal form of cefoperazone sodium | 
| CN103951679B (zh) * | 2014-04-29 | 2016-04-27 | 悦康药业集团有限公司 | 一种头孢哌酮钠化合物及其药物组合物 | 
| CN104327099A (zh) * | 2014-09-29 | 2015-02-04 | 联合康兴(北京)医药科技有限公司 | 头孢哌酮钠化合物实体及组合物和用途 | 
| CN105440057B (zh) * | 2015-11-25 | 2017-10-17 | 华北制药河北华民药业有限责任公司 | 一种制备头孢哌酮钠的方法 | 
| CN112442048B (zh) * | 2020-11-10 | 2022-04-08 | 华北制药河北华民药业有限责任公司 | 一种头孢匹胺钠的制备方法 | 
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4087424A (en) * | 1974-05-09 | 1978-05-02 | Toyama Chemical Co., Ltd. | Novel penicillins and cephalosporins and process for producing the same | 
| GB1508071A (en) * | 1976-01-19 | 1978-04-19 | Toyama Chemical Co Ltd | Cephalosporins and process for producing the same | 
| DE2600880C2 (de) * | 1976-01-12 | 1984-09-13 | Toyama Chemical Co. Ltd., Tokio / Tokyo | Cephalosporinverbindungen | 
| IL53427A0 (en) * | 1976-11-24 | 1978-01-31 | Lilly Co Eli | Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration | 
- 
        1983
        
- 1983-02-07 US US06/464,223 patent/US4456753A/en not_active Expired - Lifetime
 
 - 
        1984
        
- 1984-02-01 DE DE8484300616T patent/DE3461802D1/de not_active Expired
 - 1984-02-01 EP EP84300616A patent/EP0118196B1/en not_active Expired
 - 1984-02-02 GR GR73685A patent/GR81694B/el unknown
 - 1984-02-03 CA CA000446699A patent/CA1190220A/en not_active Expired
 - 1984-02-03 NZ NZ207038A patent/NZ207038A/en unknown
 - 1984-02-03 PT PT78058A patent/PT78058B/pt unknown
 - 1984-02-06 DK DK051784A patent/DK152757C/da not_active IP Right Cessation
 - 1984-02-06 KR KR1019840000544A patent/KR870001071B1/ko not_active Expired
 - 1984-02-06 IL IL70872A patent/IL70872A/xx not_active IP Right Cessation
 - 1984-02-06 FI FI840475A patent/FI75571C/fi not_active IP Right Cessation
 - 1984-02-06 AU AU24209/84A patent/AU541675B2/en not_active Expired
 - 1984-02-06 YU YU206/84A patent/YU43562B/xx unknown
 - 1984-02-06 ZA ZA84853A patent/ZA84853B/xx unknown
 - 1984-02-06 HU HU84478A patent/HU190544B/hu unknown
 - 1984-02-06 PL PL1984246090A patent/PL146540B1/pl unknown
 - 1984-02-06 ES ES529485A patent/ES8504700A1/es not_active Expired
 - 1984-02-06 IE IE273/84A patent/IE56752B1/en not_active IP Right Cessation
 - 1984-02-07 PH PH30210A patent/PH19052A/en unknown
 - 1984-02-07 JP JP59020696A patent/JPH0643429B2/ja not_active Expired - Lifetime
 
 - 
        1987
        
- 1987-08-27 SG SG700/87A patent/SG70087G/en unknown
 - 1987-12-24 HK HK996/87A patent/HK99687A/en not_active IP Right Cessation
 
 
Also Published As
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| DE3721913A1 (de) | Kristallines hydrat der 7ss-((z)-2-(2-aminothiazol-4-yl)-4-carboxybut-2-enoylamino)-3-cephem-4-carbonsaeure und dieses enthaltende zusammensetzung | |
| DE3327449A1 (de) | Eine neue form von cefuroximester, verfahren zu dessen herstellung und diesen enthaltende zusammensetzung | |
| US4456753A (en) | Process for the manufacture of highly crystalline sodium cefoperazone | |
| US4775751A (en) | Process for cephalexin hydrochloride alcoholates | |
| EP0112550B1 (de) | Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung | |
| EP0078532A2 (de) | Kristalline Salze von Cefodizim und Verfahren zu ihrer Herstellung | |
| KR100200242B1 (ko) | 클라불란산염의 제조 방법 | |
| JPH0641143A (ja) | クラブラン酸塩の製造方法 | |
| US2875247A (en) | Refining of tetracycline antibiotics by direct mash extraction | |
| US4219641A (en) | Process for preparing erythromycin succinate | |
| EP0101170B1 (en) | Process for the manufacture of sodium cefoperazone | |
| DD261163A5 (de) | Verfahren zur reinigung von cephalosporin-antibiotika | |
| US3905959A (en) | Process for the manufacture of crystalline anhydrous ampicillin | |
| CA1079736A (en) | Crystalline calcium di-clavulanate dihydrate | |
| US4168376A (en) | Process for crystalline sodium cefamandole | |
| EP0018760B1 (en) | D-sesquisodium salt of an oxa-beta-lactam diacid compound and its preparation | |
| KR0169534B1 (ko) | 고밀도의 고결정성 세포페라존 나트륨염 및 그의 제조방법 | |
| US3676427A (en) | Process for the manufacture of the disodium salt of alpha-carboxybenzylpenicillin | |
| JPH0665254A (ja) | セフォラニド誘導体 | |
| GB2144423A (en) | 1-Methyl-5-nitro-imidazole derivatives | |
| DE1670637A1 (de) | Neues Cephalosporinantibioticum und Verfahren zu seiner Herstellung |